Skip to main content

and
  1. Article

    Open Access

    Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Currently, the cause of psoriatic arthritis (PsA) is unknown, and the effectiveness of current drug treatments is unsatisfactory. In March 2019, the US Food and Drug Administration (FDA) approved risankizumab,...

    Qin-Yi Su, Hao-Nan Zhou, Guo-Mei **a, Rui-Yuan Zhang in Rheumatology and Therapy (2024)

  2. No Access

    Article

    Using the Metabolome to Understand the Mechanisms Linking Chronic Arsenic Exposure to Microglia Activation, and Learning and Memory Impairment

    The activation of microglia is a hallmark of neuroinflammation and contributes to various neurodegenerative diseases. Chronic inorganic arsenic exposure is associated with impaired cognitive ability and increa...

    Rui-Yuan Zhang, Jie-Bai Tu, Rui-Tu Ran, Wen-Xuan Zhang, Qiang Tan in Neurotoxicity Research (2021)